Results 91 to 100 of about 6,539 (194)

Profile of leptin, adiponectin, and body fat in patients with hyperprolactinemia: Response to treatment with cabergoline

Indian Journal of Endocrinology and Metabolism, 2016
Introduction: Though hypoadiponectinemia and leptin resistance have been proposed as potential factors for weight gain in patients with hyperprolactinemia (HPL), the effects of HPL and cabergoline on these adipocyte-derived hormones are not clear.
Nazir Ahmad Pala, Bashir Ahmad Laway, Raiz Ahmad Misgar, Zaffar Amin Shah, Tariq A Gojwari, Tariq A Dar   +5 more
doaj   +1 more source

Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. [PDF]

, 2010
Context: Data concerning the safety for pregnancy of cabergoline treatment in hyperprolactinaemic women are still scarce. Objective: To exclude a higher than normal risk for miscarriage and congenital malformation in pregnancies initiated under ...
Hubinont, Corinne, Maiter, Dominique, Lebbe, Marie, Bernard, Pierre   +3 more
core   +1 more source

Growth hormone deficiency, secondary hypothyroidism, and empty sella following treatment of childhood macroprolactinoma

Indian Journal of Endocrinology and Metabolism, 2013
Macroprolactinoma are rare in childhood, especially in the first decade. A 9-year-old girl presented with headache, vomiting, and decreased vision for 8 months. A diagnosis of macroprolactinoma was made following documentation of elevated serum prolactin
Chitra Selvan, Deep Dutta, Sujoy Ghosh, Satinath Mukhopadhyay, Subhankar Chowdhury   +4 more
doaj   +1 more source

Use of Cabergoline in Prolactinomas [PDF]

, 1998
Bromocriptine (BRC), the standard medication for prolactinomas, is effective in most cases but has a short half-life and occasional side effects. Cabergoline (CAB, Dostinex) is a potent D2-selective dopamine agonist, FDA-approved since12/1996 for ...
Victoria Pelak, MD; G. T. Liu, MD; S. L. Galetta, MD; N. Butler; A. Stein; L. Bolinger
core  

Use of the dopamine agonist cabergoline in the treatment of movement disorders [PDF]

, 2002
Cabergoline is an ergot-derived dopamine agonist used in the treatment of Parkinson's disease (PD). Both ergot and non-ergot-derived dopamine agonists directly stimulate dopamine receptors, unlike levodopa, which must undergo presynaptic breakdown to ...
Marco, Aimee Di, Chaudhuri, K Ray, Appiah-Kubi, Linda S   +2 more
core   +1 more source

Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report

Journal of Medical Case Reports, 2019
Background Prolactinomas are tumors of the pituitary gland that usually respond very well to treatment with cabergoline. Resistance to cabergoline is very rare, but when it occurs, it is a difficult problem to resolve if the tumor is inoperable.
Luiz Augusto Casulari, Lucas Faria de Castro, Iruena Moraes Kessler, José Luiz Mendonça, Maria de Fátima Magalhães Gonzaga   +4 more
doaj   +1 more source

Inhibiting prolactin by cabergoline accelerates mammary gland remodeling during the early dry period in dairy cows [PDF]

, 2017
The inhibition of prolactin release using cabergoline, a dopamine agonist, is an effective strategy to accelerate the changes in mammary secretion composition after drying-off.
M. Boutinaud, N. Isaka, Gandemer, Eva, E. Gandemer, P. Lamberton, V. Lollivier, de Prado Taranilla, A.I., Lamberton, Philippe, Sordillo, L M, Wiart, Sandra, A. I. De Prado Taranilla, Isaka, N, Lollivier, Vanessa, Boutinaud, Marion, S. Wiart, L.M. Sordillo, De Prado Taranilla, A I   +16 more
core   +1 more source

A fatal overdose of the ergot derivative cabergoline [PDF]

, 2004
Cabergoline,Whole blood,Poisoning ...
Johansen, Sys Stybe, Karkov, Jens Nissen Dyrlund   +1 more
core  

Cabergoline for migraine prevention (PROTECT): Protocol for a randomized, placebo-controlled, double-blind trial

Cephalalgia Reports
Cabergoline, a dopamine receptor agonist, has shown beneficial effects as a preventive treatment for migraine, with no serious adverse events reported.
Astrid Johannesson Hjelholt, Kristina Laugesen, Randi Maria Hanghøj Tei, Helge Kasch, Hans-Christoph Diener, Jens Otto Lunde Jørgensen   +5 more
doaj   +1 more source

Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study [PDF]

, 2007
The effectiveness of cabergoline in 50 men with psychogenic erectile dysfunction was investigated in a 4-month, randomized, placebo-controlled, double-blind study with validated psychological tests, and prolactin, follicle-stimulating hormone ...
Loew, T, Moleda, D, Rother, W, Nickel, M, Gil, F Pedrosa   +4 more
core   +1 more source